Showing results (151-160 of 1,343) with videos related to
Sort By:
Pageof 135
The Pharmacogenomics Journal|January 26, 2005
Correlating gene expression with chemical scaffolds of cytotoxic agents: ellipticines as substrates and inhibitors of MDR1Y Huang, P E Blower, C Yang, et al.The Pharmacogenomics Journal|September 29, 2004
Identification of single-nucleotide polymorphisms of the human neurokinin 1 receptor gene and pharmacological characterization of a Y192H variantG P Randolph, J S Simon, M G Arreaza, et al.The Pharmacogenomics Journal|October 30, 2003
Association of dopaminergic and serotonergic genes with tardive dyskinesia in patients with chronic schizophreniaR H Segman, T Goltser, U Heresco-Levy, et al.The Pharmacogenomics Journal|September 11, 2008
Nicotine abstinence genotyping: assessing the impact on smoking cessation clinical trialsG R Uhl, T Drgon, C Johnson, et al.The Pharmacogenomics Journal|June 14, 2017
On the readiness of physicians for pharmacogenomics testing: an empirical assessmentN Amara, J Blouin-Bougie, D Bouthillier, et al.The Pharmacogenomics Journal|June 14, 2017
Urinary Lipidomics: evidence for multiple sources and sexual dimorphism in healthy individualsJ Graessler, C S Mehnert, K-M Schulte, et al.The Pharmacogenomics Journal|June 21, 2017
Pharmacogenetic biomarkers of response in Crohn's diseaseT M Linares-Pineda, M Cañadas-Garre, A Sánchez-Pozo, et al.The Pharmacogenomics Journal|August 11, 2018
Cross-ethnicity tagging SNPs for HLA alleles associated with adverse drug reactionMichael Erlichster, Benjamin Goudey, Efstratios Skafidas, et al.The Pharmacogenomics Journal|March 17, 2010
Why do young women smoke? VI. A controlled study of nicotine effects on attention: pharmacogenetic interactionsA Rigbi, A Yakir, K Sarner-Kanyas, et al.The Pharmacogenomics Journal|June 30, 2018
UGT1A1 polymorphisms associated with prolactin response in risperidone-treated children and adolescents with autism spectrum disorderYaowaluck Hongkaew, Sadeep Medhasi, Ekawat Pasomsub, et al.Pageof 135